Implement State-of-the-Art, Reproducible & Predictive in vivo & in vitro Oncology Models to Successfully Identify Promising Targets & Biomarkers, & Surmount the Translational Gap
Welcome to the 9th Tumor Models San Francisco Summit
Waves of new models are being validated. A wider industry shift to precision oncology is requiring more specific genetic models. Availability and cost-effectiveness of sequencing and computational tools are enabling better and more accessible characterization of therapeutic pathways than ever before. The challenges and opportunities in preclinical and translational research are constantly evolving, and it has never been more critical to benchmark and share cross-industry learnings and case studies to de-risk the move to the clinic.
Reuniting 180+ Preclinical, Translational, Discovery, Pharmacology, and Biology experts to share case studies in improving target selection, facilitating biomarker discovery, and achieving clinical translatability, the 9th Tumor Models San Francisco Summit is the definitive industry forum uniting the West Coast ecosystem of pharma and biotech to collaboratively advance the frontier of oncology research to the clinic.
Why Attend?
Unlock Advanced Model Selection Criteria:
Interrogate Case Studies in ADCs, CAR-T, Cytokines & More:
Enhance Precision Medicine with Advanced Tools:
Analyze the translational relevance of in vivo and in vitro models and navigate cost-benefit analysis to identify optimal models across different therapeutic areas
Learn how industry leaders are optimizing processes and accelerating model selection across different modalities to apply learnings to your research
Leverage digital pathology, sequencing, AI and omics research to advance understanding of the tumor microenvironment across specific disease subsets and supercharge therapeutic development
Expert Speakers Include
What Past Attendees Enjoyed
“Cutting edge new models and scientific information in IO, resistance strategy, and preclinic screening to increase clinic success”
AbbVie
“Exceptional organization, showcasing the pinnacle of new advancements within the industry through engaging talks and distinguished speakers. A highly valuable and enriching experience"
Appia Bio
“A truly focused conference allowing for open discussion”
Sardona Therapeutics
“Collaborative, interactive, and dynamic”
Arsenal Bio
“From a CRO perspective, lots of good interactions with clients”
Certis Oncology